title: Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.
abstract: The surgical management for recurrent endolymphatic stromal myosis metastatic to the inferior vena cava is described. Positive estrogen and progesterone receptors in the resected tumor are reported. A plan of therapy is suggested for patients with endolymphatic stromal myosis, including a rationale for adjuvant progestin therapy.
authors.affiliation: Department of Obstetrics and Gynecology, Saint Joseph Hospital, Denver, Colorado 80205.
authors.forename: T W
authors.initials: TW
authors.lastname: Montag
authors.forename: F D
authors.initials: FD
authors.lastname: Manart
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003692:Delayed-Action Preparations; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D009360:Neoplastic Cells, Circulating; D010386:Pelvic Neoplasms / Q000032:analysis / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012082:Renal Veins / Q000473:pathology; D012509:Sarcoma / Q000032:analysis / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D014682:Vena Cava, Inferior / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D004966:Estrogens, Conjugated (USP); D006728:Hormones; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone